1. Home
  2. HSCS vs XYLO Comparison

HSCS vs XYLO Comparison

Compare HSCS & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSCS
  • XYLO
  • Stock Information
  • Founded
  • HSCS 2007
  • XYLO 1999
  • Country
  • HSCS United States
  • XYLO Israel
  • Employees
  • HSCS N/A
  • XYLO N/A
  • Industry
  • HSCS Medical Specialities
  • XYLO
  • Sector
  • HSCS Health Care
  • XYLO
  • Exchange
  • HSCS Nasdaq
  • XYLO NYSE
  • Market Cap
  • HSCS 3.2M
  • XYLO 3.1M
  • IPO Year
  • HSCS 2022
  • XYLO N/A
  • Fundamental
  • Price
  • HSCS $3.17
  • XYLO $4.86
  • Analyst Decision
  • HSCS Strong Buy
  • XYLO
  • Analyst Count
  • HSCS 2
  • XYLO 0
  • Target Price
  • HSCS $13.50
  • XYLO N/A
  • AVG Volume (30 Days)
  • HSCS 15.1K
  • XYLO 13.1K
  • Earning Date
  • HSCS 03-13-2025
  • XYLO 09-20-2024
  • Dividend Yield
  • HSCS N/A
  • XYLO N/A
  • EPS Growth
  • HSCS N/A
  • XYLO N/A
  • EPS
  • HSCS N/A
  • XYLO N/A
  • Revenue
  • HSCS $14,700.00
  • XYLO $57,642,000.00
  • Revenue This Year
  • HSCS $174.19
  • XYLO $16.76
  • Revenue Next Year
  • HSCS $4,100.00
  • XYLO $5.71
  • P/E Ratio
  • HSCS N/A
  • XYLO N/A
  • Revenue Growth
  • HSCS 151.28
  • XYLO N/A
  • 52 Week Low
  • HSCS $2.36
  • XYLO $2.70
  • 52 Week High
  • HSCS $18.50
  • XYLO $8.83
  • Technical
  • Relative Strength Index (RSI)
  • HSCS 39.08
  • XYLO 61.42
  • Support Level
  • HSCS $3.11
  • XYLO $4.02
  • Resistance Level
  • HSCS $3.45
  • XYLO $5.00
  • Average True Range (ATR)
  • HSCS 0.17
  • XYLO 0.43
  • MACD
  • HSCS -0.02
  • XYLO 0.01
  • Stochastic Oscillator
  • HSCS 8.70
  • XYLO 80.68

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

Share on Social Networks: